Diana M. Toledo

Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations

Niall J. Lennon, Leah C. Kottyan, Christopher Kachulis et al. · Nature Medicine · 2024 · 166 citations · Full text

Disease Management, Patient Selection, Polygenic Risk +18

Mycophenolate Mofetil Treatment of Systemic Sclerosis Reduces Myeloid Cell Numbers and Attenuates the Inflammatory Gene Signature in Skin

Monique Hinchcliff, Diana M. Toledo, Jaclyn Taroni et al. · Journal of Investigative Dermatology · 2018 · 62 citations · Full text

Inflammation, Translational Medicine, Autoimmune Disease +12

Utility of a virtual counselor (VICKY) to collect family health histories among vulnerable patient populations: A randomized controlled trial

Catharine Wang, Michael K. Paasche‐Orlow, Deborah J. Bowen et al. · Patient Education and Counseling · 2021 · 35 citations · Full text

Counseling, Family Medicine, Education +17

Wastewater-Based SARS-CoV-2 Surveillance in Northern New England

Diana M. Toledo, Ashlee A. Robbins, Torrey L. Gallagher et al. · Microbiology Spectrum · 2022 · 28 citations · Full text

Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome

Heather Mason‐Suares, Diana M. Toledo, Jean Gekas et al. · European Journal of Human Genetics · 2017 · 27 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Genetics +4